Lasmiditan
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Lasmiditan is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Lasmiditan is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $88.70 to $88.77 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$88.70 – $88.77
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing LASMIDITAN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
REYVOW 100 MG TABLET | $88.7715 per EA | — |
REYVOW 50 MG TABLET | $88.6973 per EA | — |
Frequently Asked Questions
What is Lasmiditan used to treat?
Lasmiditan is used to treat migraine with aura and migraine without aura, per the National Library of Medicine's MED-RT classification.
How many Lasmiditan products are on the market?
The Lasmiditan drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Lasmiditan?
NADAC reference prices for Lasmiditan range from $88.6973 to $88.7715 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Lasmiditan?
1 manufacturer lists Lasmiditan in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (2).